Concepedia

Nathalie Aucoin

NA

14

Publications

1K

Citations

12

H-Index

2012

Active since

Affiliations

Princess Margaret Cancer Centre(Current)

Hôpital Charles-Le Moyne

Ottawa Hospital

Centre Hospitalier de l’Université de Montréal

Juravinski Cancer Centre

Nathalie Aucoin is an author at Princess Margaret Cancer Centre specializing in oncology, radiation oncology, and medicine.

Top concepts

Publications per year

2012–2023

14

Publications

14

Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer

Eric X. Chen, Derek J. Jonker, Jonathan M. Loree et al. · JAMA Oncology · 2020 · 377 citations · Full text

Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced <i>ERBB2/HER2</i>-Positive Metastatic Breast Cancer

Virginia F. Borges, Cristiano Ferrario, Nathalie Aucoin et al. · JAMA Oncology · 2018 · 162 citations · Full text

Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial

Christophe Tournigand, Benoist Chibaudel, Benoît Samson et al. · The Lancet Oncology · 2015 · 120 citations

, , +8

The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma

Daniel J. Renouf, Jonathan M. Loree, Jennifer J. Knox et al. · Nature Communications · 2022 · 119 citations · Full text

Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer

Eric X. Chen, Jonathan M. Loree, Emma Titmuss et al. · JAMA Network Open · 2023 · 55 citations · Full text

Rows per page

1–5 of 14